{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:08:11Z","timestamp":1742389691842},"reference-count":73,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2018,12,2]]},"DOI":"10.1080\/14787210.2018.1542300","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T17:30:36Z","timestamp":1540834236000},"page":"865-876","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Meropenem\u2013vaborbactam for adults with complicated urinary tract and other invasive infections"],"prefix":"10.1080","volume":"16","author":[{"given":"Owen R.","family":"Albin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Twisha S.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, University of Michigan Hospitals and Health Centers, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"issue":"169","key":"CIT0001","first-page":"1","volume":"13","author":"Schappert SM","year":"2011","journal-title":"Vital Health Stat"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1186\/2047-2994-2-5"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.09.002"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.10.002"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl035"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2383-z"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.174"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx063"},{"key":"CIT0009","unstructured":"Jacob JT, et al. Vital signs: carbapenem-resistantEnterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62(9):165\u2013170."},{"key":"CIT0010","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. 2013 [cited 2018 May 16] Available from: https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf"},{"issue":"1","key":"CIT0011","first-page":"15","volume":"3","author":"Meletis G","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70190-7"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00299-07"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05440-11"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.03.003"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3201\/eid1710.110655"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.05.002"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00387-11"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03514.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06268-11"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02166-13"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis588"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv086"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.11.001"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00440-16"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-15"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.012"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02123-13"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00883-17"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix783"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01165-15"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00678-15"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw636"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528040-00002"},{"key":"CIT0036","volume-title":"Meropenem-vaborbactam [package insert]","year":"2017"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.02.021"},{"issue":"62","key":"CIT0038","volume":"21","author":"Hackel MA","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"61","key":"CIT0039","volume":"24","author":"Lomovskaya O","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00567-17"},{"issue":"4","key":"CIT0041","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/j.1875-9114.1997.tb03742.x","volume":"17","author":"Fish DN","year":"1997","journal-title":"Pharmacotherapy"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1086\/338782"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01456.x"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.02.021"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01969-17"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01694-17"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00568-16"},{"key":"CIT0048","volume-title":"Meropenem [package insert]","year":"2006"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02228-17"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01713-15"},{"key":"CIT0051","volume-title":"2nd ASM Microbe","author":"Trang MGD","year":"2017"},{"key":"CIT0052","volume-title":"2nd ASM Microbe","author":"Bhavnani SMHJ","year":"2017"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02103-17"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1086\/590064"},{"key":"CIT0055","volume-title":"Presented at: 2nd ASM Microbe","author":"Griffith DC","year":"2017"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0438"},{"key":"CIT0057","unstructured":"US Food and Drug Administration Guidance for Industry. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases: guidance for industry. FDA. 2017 Aug [cited 2018 May 27] Available from: https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM359184.pdf"},{"key":"CIT0058","unstructured":"Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, et al. Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial. Infect Dis Ther. 2018 Oct 1 [ePublication ahead of print]."},{"key":"CIT0059","volume-title":"Presented at ID week","author":"Lomovskaya O","year":"2017"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.4.408"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1080\/03602530701690341"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L486"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-4-200702200-00005"},{"key":"CIT0064","unstructured":"[cited 2018 May 8] Available from: https:\/\/www.nasdaq.com\/press-release\/melinta-therapeutics-announces-vabomere-meropenem-and-vaborbactam-granted-new-technology-addon-20180803-00688"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00633-16"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx139"},{"key":"CIT0067","volume-title":"European congress of clinical microbiology and infectious diseases","author":"Motsch J","year":"2018"},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"S537","DOI":"10.1093\/ofid\/ofx163.1399","volume":"4","author":"Portsmouth S","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"CIT0069","volume-title":"Poster 1853 IDWeek","author":"McKinnell JACL","year":"2017"},{"key":"CIT0070","volume-title":"Poster 1855.IDWeek","author":"Cloutier DJKA"},{"key":"CIT0071","volume-title":"Presented at: IDWeek","author":"Kaye KS","year":"2017"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2016.4237"},{"key":"CIT0073","unstructured":"Tetraphase announces top-line results from IGNITE2 phase 3 clinical trial of eravacycline in cUTI. Available from: http:\/\/ir.tphase.com\/releasedetail.cfm?releaseid=930613. Accessed 10 October 2018."}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2018.1542300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T21:33:08Z","timestamp":1720733588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2018.1542300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,2]]}},"alternative-id":["10.1080\/14787210.2018.1542300"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2018.1542300","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}